Asterias Biotherapeutics, Inc. Files Registration Statement for Underwritten Public Offering

MENLO PARK, Calif. & ALAMEDA, Calif.-- --Asterias Biotherapeutics, Inc., a subsidiary of BioTime, Inc. , announced today that Asterias has filed a registration statement with the Securities and Exchange Commission for an underwritten public offering of up to $15,000,000 of units with each unit consisting of one share of Series B common stock and ... (more)

http://www.businesswire.com/portal/site/topix/index.jsp?ndmViewId=news_view&newsId=20131202005396&newsLang=en&ndmConfigId=1000639&vnsId=41